Taysha Gene Therapies (TSHA) Misses Q1 EPS by 2c
Get Alerts TSHA Hot Sheet
Join SI Premium – FREE
Taysha Gene Therapies (NASDAQ: TSHA) reported Q1 EPS of ($0.12), $0.02 worse than the analyst estimate of ($0.10).
For earnings history and earnings-related data on Taysha Gene Therapies (TSHA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- GameStop CEO Cohen buys 1.15M shares
- Kotak Starts INDO-MIM Ltd (INDOMIM:IN) at Reduce (3)
- Bernstein SocGen Group Upgrades Engie SA (ENGI:FP) (ENGIY) to Outperform
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share